P. S. Sarin

2.2k total citations · 2 hit papers
38 papers, 1.8k citations indexed

About

P. S. Sarin is a scholar working on Immunology, Agronomy and Crop Science and Virology. According to data from OpenAlex, P. S. Sarin has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 13 papers in Agronomy and Crop Science and 12 papers in Virology. Recurrent topics in P. S. Sarin's work include T-cell and Retrovirus Studies (16 papers), Animal Disease Management and Epidemiology (13 papers) and HIV Research and Treatment (12 papers). P. S. Sarin is often cited by papers focused on T-cell and Retrovirus Studies (16 papers), Animal Disease Management and Epidemiology (13 papers) and HIV Research and Treatment (12 papers). P. S. Sarin collaborates with scholars based in United States, France and United Kingdom. P. S. Sarin's co-authors include Rosella Gallo, M Popovic, Daniel Zagury, J Minowada, David G. Mann, V. S. Kalyanaraman, Rémi Cheynier, Jacky Bernard, M. Feldman and R. Leonard and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

P. S. Sarin

38 papers receiving 1.6k citations

Hit Papers

Isolation and Transmission of Human Retrovirus (Human T-C... 1983 2026 1997 2011 1983 1986 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. S. Sarin United States 15 1.1k 616 587 507 340 38 1.8k
M. F. McLane United States 17 1.2k 1.1× 1.6k 2.5× 476 0.8× 287 0.6× 880 2.6× 25 2.6k
Eiji Ido Japan 23 548 0.5× 693 1.1× 349 0.6× 282 0.6× 592 1.7× 82 1.7k
Sonia Van Dooren Belgium 26 1.1k 1.0× 395 0.6× 823 1.4× 660 1.3× 328 1.0× 62 2.0k
W. A. Blattner United States 21 1.7k 1.5× 196 0.3× 1.2k 2.0× 1.1k 2.1× 161 0.5× 44 2.1k
J E Groopman United States 9 466 0.4× 484 0.8× 182 0.3× 122 0.2× 364 1.1× 9 1.0k
W A Blattner United States 17 534 0.5× 230 0.4× 280 0.5× 234 0.5× 156 0.5× 26 898
Anthony Hoffman United States 10 764 0.7× 1.1k 1.9× 263 0.4× 125 0.2× 670 2.0× 11 1.8k
P. D. Markham United States 15 532 0.5× 433 0.7× 260 0.4× 203 0.4× 222 0.7× 21 1.2k
Claude E. Monken United States 18 566 0.5× 308 0.5× 343 0.6× 280 0.6× 253 0.7× 25 1.2k
D Dina United States 28 816 0.7× 1.3k 2.2× 376 0.6× 172 0.3× 1.0k 3.0× 44 2.9k

Countries citing papers authored by P. S. Sarin

Since Specialization
Citations

This map shows the geographic impact of P. S. Sarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. S. Sarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. S. Sarin more than expected).

Fields of papers citing papers by P. S. Sarin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. S. Sarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. S. Sarin. The network helps show where P. S. Sarin may publish in the future.

Co-authorship network of co-authors of P. S. Sarin

This figure shows the co-authorship network connecting the top 25 collaborators of P. S. Sarin. A scholar is included among the top collaborators of P. S. Sarin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. S. Sarin. P. S. Sarin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zimmerman, Daniel H., et al.. (1998). Cross-Clade p17 Peptide Recognition by Antisera to HGP-30, a 30-Amino Acid Synthetic Peptide Antigen from HIV Type 1 p17. AIDS Research and Human Retroviruses. 14(9). 741–749. 7 indexed citations
3.
Sarin, P. S., Carlos A. Mora, Paul H. Naylor, et al.. (1995). HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID mice.. PubMed. 41(3). 401–7. 17 indexed citations
4.
Willer, Andreas, Adnane Achour, A Lachgar, et al.. (1992). Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virus. Biomedicine & Pharmacotherapy. 46(8). 359–365. 6 indexed citations
5.
Naylor, Paul H., Janet E. Kirkley, John Mandeli, et al.. (1992). Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.. PubMed. 5(4). 382–90. 11 indexed citations
6.
Desportes, Isabelle, et al.. (1989). Expression of HIV Antigens at the Surface of Infected T4 Cells: Immunoelectron Microscopic Evidence of an Immunogenic Phase Prior to the Viral Release. AIDS Research and Human Retroviruses. 5(1). 107–114. 3 indexed citations
7.
Sei, Yoshitatsu, Peter H. Tsang, I S Wallace, et al.. (1989). Inverse relationship between HIV-1 p24 antigenemia, anti-p24 antibody and neutralizing antibody response in all stages of HIV-1 infection. Immunology Letters. 20(3). 223–230. 14 indexed citations
8.
Cheynier, Rémi, F. Lauré, Brigitte Réveil, et al.. (1988). HIV-1 Expression by T8 Lymphocytes After Transfection. AIDS Research and Human Retroviruses. 4(1). 43–50. 6 indexed citations
9.
Sei, Yoshitatsu, et al.. (1988). Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: A double-blind study. Journal of Clinical Immunology. 8(6). 464–472. 23 indexed citations
10.
Sarin, P. S.. (1988). Molecular Pharmacologic Approaches to the Treatment of Aids. The Annual Review of Pharmacology and Toxicology. 28(1). 411–428. 31 indexed citations
11.
Sarin, P. S. & R C Gallo. (1988). Lymphotropic Retroviruses of Animals and Man. PubMed. 32. 227–250. 4 indexed citations
12.
Sarin, P. S.. (1988). HTLV-I, Adult T-Cell leukemia, and tropical spastic paraparesis. Annals of Neurology. 23(S1). S181–S184. 26 indexed citations
13.
Naylor, Paul H., Seiji Wada, Goldstein Al, et al.. (1987). Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.. Proceedings of the National Academy of Sciences. 84(9). 2951–2955. 57 indexed citations
14.
Lauré, F., R. Leonard, Z Lurhuma, et al.. (1987). Genomic Diversity of Zairian HIV Isolates: Biological Characteristics and Clinical Manifestation of HIV Infection. AIDS Research and Human Retroviruses. 3(4). 343–353. 5 indexed citations
15.
Réveil, Brigitte, et al.. (1986). Evidence for HTLV‐III/LAV expression by primary cultures of T8 cells. International Journal of Cancer. 38(5). 657–659. 4 indexed citations
17.
Zagury, Daniel, et al.. (1985). Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell line.. PubMed. 45(9 Suppl). 4595s–4597s. 9 indexed citations
18.
Salahuddin, S. Zaki, P. D. Markham, Joseph E. Gootenberg, et al.. (1984). Lymphokine Production by Cultured Human T Cells Transformed by Human T-Cell Leukemia-Lymphoma Virus-I. Science. 223(4637). 703–707. 161 indexed citations
19.
Sarin, P. S. & R C Gallo. (1983). Human T-cell leukemia-lymphoma virus (HTLV).. PubMed. 13. 149–61. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026